Caelus Re Ltd.
The Artemis Catastrophe Bond and Insurance-linked Securities Deal Directory aims to provide a one-stop resource for information on every cat bond and ILS transaction we hold information on. The content of this Deal Directory is provided as is and there will be some omissions. Help us to keep these cat bond and ILS transaction summaries up to date by contacting us if you see an error or omission that you can correct.
Caelus Re Ltd. - At a glance:
- Issuer / SPV: Caelus Re Ltd.
- Cedent / Sponsor: Nationwide Mutual Insurance Co.
- Placement / structuring agent/s: ?
- Risk modelling / calculation agents etc: AIR Worldwide
- Risks / Perils covered: U.S. hurricane, U.S. earthquake
- Size: $250m
- Trigger type: Indemnity
- Ratings: S&P: 'BB+'
- Date of issue: Jun 2008
- Artemis.bm news coverage: Articles discussing Caelus Re Ltd. from Artemis.bm
Caelus Re Ltd. - Full details
Caelus Re Ltd. has issued $250 million Series 2008-1 Class A variable-rate notes under this deal for Nationwide Mutual. The notes are an initial offering by this SPV.
Nationwide Mutual Insurance Co. and certain of its subsidiaries and affiliates have entered into a reinsurance agreement with Caelus Re to provide them with a source of indemnified multi-year reinsurance coverage.
The notes cover, and are exposed to, first and subsequent U.S. hurricanes and earthquakes, including fire following, on a per occurrence basis.
The notes have been rated BB+ by Standard and Poor’s based on the probability of attachment as modelled by AIR Worldwide, annualized probability of attachment is 1.36%.
For year one the notes cover from the initial trigger amount of $2.25 billion up to the intial exhaustion point of $2.528 billion.
The Artemis Catastrophe Bond & Insurance-Linked Securities Deal Directory is copyright © Steve Evans Ltd. Reproduction or publication without permission is not permitted. Use of this information within a commercial product, or for profit, without a license is strictly prohibited. Contact us if you would like to use this content or to discuss licensing.